Literature DB >> 6986200

Malignant lymphoma with primary manifestation in the gonad: a clinicopathologic study of 38 patients.

R R Paladugu, R M Bearman, H Rappaport.   

Abstract

This study is based on 38 patients, each of whom had a malignant lymphoma in which the gonad was the site of the main tumor mass at the time of diagnosis. Histiocytic lymphoma was the predominant type in the 27 male patients; in the 11 female patients, poorly differentiated lymphocytic lymphoma was the most frequent type (36%). All of the neoplasms in the males were diffuse, whereas two of the females had neoplasms that were nodular and diffuse. A striking feature was the high frequency of vascular invasion (41%) in the testicular lymphomas, which was reflected in a high incidence (86%) of noncontiguous lung involvement at autopsy, suggesting hematogenous spread. Clinically occult disease is probably responsible for the short interval between the discovery of a gonadal mass and the appearance of generalized disease. A poor prognosis may be expected if there is evidence of generalized disease within one year after diagnosis. Only 2 patients had disseminated disease after a year, whereas all those who died of disseminated disease manifested it within six months after diagnosis. Disease-freee survival times in excess of 60 months in 3 patients who were treated only by orchiectomy or oophorectomy indicate that the gonads may be the primary site of a malignant lymphoma.

Entities:  

Mesh:

Year:  1980        PMID: 6986200     DOI: 10.1002/1097-0142(19800201)45:3<561::aid-cncr2820450324>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.

Authors:  Xiao-Ying Zhao; Xiao-Nan Hong; Jun-Ning Cao; Shiang-Jiin Leaw; Ye Guo; Zi-Ting Li; Jian-Hua Chang
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

2.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

3.  Primary ovarian lymphoma in an infant: report of a case.

Authors:  A Türken; A O Ciftci; Z Akçören; V Köseoglu; D Akata; M E Senocak
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour.

Authors:  W G Horstmann; W Timens
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

5.  Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.

Authors:  Asima Kaleem Ahmad; Pei Hui; Babak Litkouhi; Masoud Azodi; Thomas Rutherford; Shirley McCarthy; Mina LuQing Xu; Peter E Schwartz; Elena Ratner
Journal:  Int J Gynecol Cancer       Date:  2014-09       Impact factor: 3.437

6.  Follicular dendritic cells in extranodal non-Hodgkin lymphomas of MALT and non-MALT type.

Authors:  C Fellbaum; J Sträter; M L Hansmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Non-Hodgekin's lymphoma of female genital tract: a case report.

Authors:  Noor-I-Kiran Naeem; Farhatulain Ahmed; Shamila Yasir
Journal:  Med J Islam Repub Iran       Date:  2013-05

8.  Ovarian lymphoma.

Authors:  Julian A Crasta; Elizabeth Vallikad
Journal:  Indian J Med Paediatr Oncol       Date:  2009-01

9.  T-cell lymphoma masquerading as extrapulmonary tuberculosis: case report and review of literature.

Authors:  Piyush Ranjan; Sourabh Dutta; Aanchal Kakkar; Ankur Goyal; Naval K Vikram; Mehar C Sharma; Rita Sood
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

Review 10.  Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.

Authors:  Anna Stepniak; Piotr Czuczwar; Piotr Szkodziak; Ewa Wozniakowska; Slawomir Wozniak; Tomasz Paszkowski
Journal:  Arch Gynecol Obstet       Date:  2017-08-02       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.